Presentation at ENAR 2023 spring meeting

Inao T, Yokota I. Exact sequential single-arm trial design with curtailment for binary endpoint. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN. Fuyama K, Yokota I. Probabilistic index for survival analysis using landmark time, clinically significant differences, and multiple prioritized endpoints: a simulation study. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN.

Unoki’s paper is published in Viruses

Nakakubo S*, Unoki Y*, Kitajima K, Terada M, Gatanaga H, Ohmagari N, Yokota I, Konno S. Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses. 2023; 15(3):671. https://doi.org/10.3390/v15030671 * Equally contributed

Fuyama’s paper is published in Statistics in Medicine

Fuyama K, Ogawa M, Mizusawa J, Kanemitsu Y, Fujita S, Kawahara T, Sakamaki K, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Stat Med. 2023 Feb 27. doi: 10.1002/sim.9690. Epub ahead of print. PMID: 36849124.

Presentation at ISCB43

Okada K, Yokota I. Two one-sided test-then-pool method for clinical trials. ISCB43. 2022/8/24. Newcastle, UK.

Presentation at Japanese Classification Society 2021 symposium

Inao T, Yokota I. Comparison of sequential test for binary outcome. Japanese Classification Society2021 symposium, Okinawa, Japan, Dec 12, 2021. Okura H, Inao T, Yokota I. Estimation of restricted mean survival time for interval-censored data usingmidpoint imputation. Japanese Classification Society 2021 symposium, Okinawa, Japan, Dec 11, 2021.

IY, KO, YU and YY from our lab e-published a new paper in Lancet Microbe.

Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Iwasaki S, Fujisawa S, Nishida M, Teshima T. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. Lancet Microbe. doi: 10.1016/S2666-5247(21)00092-6 Press releasehttps://www.global.hokudai.ac.jp/blog/a-rapid-antigen-test-for-sars-cov-2-in-saliva/

IY, KO, YU, YY and IT from our lab published a new paper in Clin Infect Dis.

Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T. Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clin Infect Dis. 2020 Sep 25:ciaa1388. doi: 10.1093/cid/ciaa1388. Epub ahead of print. PMID: 32976596.